Both molecules are upregulated under inflammatory conditions in this cancer, mimicked by IFN-γ stimulation in vitro (Figure 1 and Figure 5a) and by treatment of xenograft tumors with GD2-specific CART in vivo [6,26] (Figure 4c). This evidence concerns the gene IFNG and cancer.